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Homogenates of human skin metabolize progesterone-4-"C to the same products as whole 
skin. Studies with subcellular fractions obtained by differential centrifugation indicate the 
presence in skin of a membrane-bound 5a-reductase and a soluble 20a-hydroxysteroid 
dehydrogenase (20a-HSD), both of which utilize TPNH as cofactor. The 20a-HSD has a pH 
optimum of 6.2 and a K,. of appnn:imately 7 JlM. Unlike placental preparations, the 105,000 
x g supernatant fraction prepared from human skin has more 20a-HSD than 17{3-hydroxy-
steroid dehydrogenase activity. This soluble skin enzyme acting on steroid hormones is 
distinct from previously reported particulate enzymes. 
Skin has been shown to metabolize several 
classes of steroids [1-5]. The enzymes catalyzing 
the reduction of the t.. '-bond of testosterone and 
progesterone [6), the .6.'-bond and 20-ketone of 
cortisol, and the oxidation of the 11{3-hydroxyl of 
cortisol (S. L. Hsia, unpublished observations) in 
human skin are membrane bound, as are the 
enzymes in the oxidation of the 17 13-hydroxyl group 
of estradiol and testosterone in rat skin [7). The 
greater portion of the estradiol-17/3 hydroxysteroid 
dehydrogenase activity in human skin prepara-
tions is membrane bound, but a small amount of 
activity remains in the 105,000 x g supernatant 
[8). Voigt et al [6) and Davis [7] have suggested 
that a few enzymes of broad specificity may be 
responsible for chemical transformations of such 
diverse steroids as testosterone, progesterone, and 
estrogens. 
In this study, we will describe the transforma-
tions of progesterone by subcellular fractions of 
human skin, confirm the finding that progesterone 
5a-reductase is membrane bound, and describe a 
soluble 20a-hydroxysteroid dehydrogenase (20a-
HSD) utilizing progesterone as substrate and 
TPNH as cofactor. The latter enzyme is distinct 
from previously reported cutaneous enzymes. 
MATERIALS AND METHODS 
Chemicals 
Radioactive steroids were purchased from New Eng-
land Nuclear Company. Specific activities were approxi-
mately 20 mCi/mmole for "C-containing compounds and 
33.5 Ci/mmole for tritiated compounds. Solutions of the 
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radioactive compounds were evaporated under nitrogen 
and the residue dissolved in methanol. After examination 
for chromatographic purity in system PG (see below), 
stock solutions containing approximately 10' dpm (8.6 
nmoles) of progesterone-4-"C in each 0.1 ml were stored 
at -10°C. Reference steroids and coenzymes were pur-
chased from Southwestern Biochemicals, Mann Research 
Laboratories, and Sigma Chemical Company. 20a-
Hydroxypregn-4-en-3-one (20a-DHP) was a gift from the 
Upjohn Company. 
Preparation of Tissue Homogenates 
Specimens of human foreskin were collected at circum-
cision and frozen at -60°C until the day of the experi-
ment. In some experiments, freshly obtained tissue was 
used, but no significant differenc~s from preparations 
utilizing frozen tissues were noted. The tissue was 
weighed and minced with scissors. The minced tissue was 
added to enough buffer (0.1 M sodium phosphate, pH 7.4, 
containing 0.25 M sucrose) to give a 10% (w/v) homoge-
nate. The skin, while chilled in an ice bath, was homoge-
nized for 1 min with a Polytron homogenizer (Kinematic a 
GMBH, Lucern, Switzerland) using a setting of 5, and 
then with a motor-driven ground-glass homogenizer ( 12 
strokes) as described by Voigt et al [6 ]. 
The homogenate was centrifuged at 100 x g for 30 min 
to remove debris and the supernatant (designated "whole 
homogenate") fraction was further centrifuged at 10,000 
x g for 30 min. The 10,000 x g pellet was washed once in 
buffer and resuspended in a volume of buffer equal to 
that of the 10,000 x g supernatant. The 10,000 x g 
supernatant was centrifuged at 105,000 x g for 1 hr and 
the 105,000 x g pellet washed with buffer. All centrifuga-
tions were at 4 °C. 
Enzymatic Assay of Subcellular Fractions 
A variable volume of the subcellular fraction to be 
assayed was mixed with 0.1 M phosphate 1:\uffer {pH 7.4) 
to give a total incubation volume of 5 mi. In experiments 
utilizin!l cofactors, 3.6 !'moles each of TPN, DPN, 
DPNH, and/or TPNH were added. In some experiments 
a TPNH generating system consisting of TPN (3.3 
!'moles), glucose-6-phosphate (12 !'moles), and glucose-
6-phosphate dehydrogenase (2 units) was used. Reaction 
was begun by the addition of 0.1 ml (8.6 !'moles) of 
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progesterone-4-''C stock solution. After incubation for 3 
hr at 37°C, the reaction was stopped and the steroids 
extracted as previously described [2]. Metabolites formed 
were separated by chromatography in system PG and 
quantitated by scanning. 
20ot-HSD Assay 
Because quantitative recovery of radioactive steroids 
by exhaustive extraction with organic solvents is tedious, 
the single extraction met~od described by Davis et al [7] 
was employed. The incubation was carried out in a 50-ml 
screw-cap centrifuge tube in which 0.1 ml of a methanolic 
solution containing 8.6 nmoles of progesterone-4-"C had 
been evaporated. One milliliter of enzyme solution and 
0.2 ml of buffer containing 31'moles ofTPNH were added 
and the mixture incubated at 37°C for I hr. The 
incubation was terminated by the addition of 100 "g each 
of carrier progesterone and 20a-DHP and 6 ml dichloro-
methane. The tube was tightly capped, shaken vigor-
ously, and the solvents allowed to separate into two 
phases. Approximately 5 ml of the lower (dichlorometh-
ane) phase was transferred by pipette to a conical-bottom 
tube and evaporated to dryness under a nitrogen jet. The 
residue was dissolved in 0.2 ml of methanol and chro-
matographed in system PG. The amount of produd 
produced was calculated from the scanning of the chro· 
matogram by use of a correction factor for the differential 
extraction of substrate and product. The correction factor 
was determined as follows: a mixture of progesterone-4-
"C and 20a-DHP-1-'H was prepared which gave an 
isotope ratio ldpm'H/dprn"Cl of 7,95. An aliquot was 
evaporated in 6 centrifuge tubes and I ml of methanolic 
carrier solution and 6 ml of dichloromethane added in 
rapid succession. The 'H and "C in the extracts were 
determined and recovery of substrate and product calcu-
lated. The mean recovery for "C was 55.5o/c with a 
standard deviation of 5.0'lt and for 'H was 76.3'!; with a 
standard deviation of 5.0W. From these values. a correc-
tion factor of 0.7 was calculated which then was used to 
correct for the preferential extraction of product. In 
experiments measuring the conversion of estrone-4- "C to 
estradiol-"C, a different factor (0.9) determined in a 
similar manner was used. 
Time studies utilizing the single extraction method 
indicated that conversion of progesterone to 20a-DHP 
was linear for 3 hr. 
Chromatography 
Residues were subjected to thin-layer chromatography 
or paper chromatography in the following systems: 
System PG was the ligroin~propylene glycol system 
described by Savard {9] and was used for progesterone 
and its metabolites. 
System BHMW was the benzene:heptane:methanol: 
water (4:6:7:3) system described by Bush [10] and was 
used to measure the conversion of estrone to estradiol-17/l 
as previously described [3 j. 
After development, paper strips were either dried for 
50 min under vacuum at 50°C or allowed to dry in the air 
for 24 hr. The distribution of radioactivity was monitored 
by a Vanguard Autoscanner 880 with automatic data 
system. The amount of radioactivity represented by each 
peak was calculated as a percentage of the total radioac-
tivity in the chromatogram. Reference compounds with 
an a, /l-unsaturated ketone structure were detected by 
examining the strip under a short-wave ultraviolet lamp. 
System TLC-CM-4 was a thin-layer chromatography 
system using chloroform: methanol {96:4) as the solvent. 
The chloroform was stabilized by 0.75% ethanol immedi-
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ately after distillation. Plates were allowed to develop 
until the solvent front had ascended 35 em, which usually 
required 3 hr. Steroids on thin-layer chromatography 
plates were visualized by exposure to iodine vapor. 
Thin-layer chromatography was performed on 40 x 5 em 
glass plates coated with silica gel H (thickness 3/8 mm). 
Plates were air dried for 30 min, activated at l00°C for 30 
min, and stored in a desiccator until used. 
Analysis of Kinetic Data 
The kinetic data were analyzed on an IBM 360/65 
computer with the aid of the Hyperb program of Hanson 
et al [11] based on the method of Bliss and James [12]. 
RESULTS 
Incubations with subcellular fractions. Incuba-
tion of progesterone with 2 ml (equivalent to 200 
mg of skin) of "whole homogenate" and all four 
cofactors (see Materials and Methods) resulted in 
chromatograms showing 6 areas of radioactivity in 
a pattern identical to that obtained previously by 
incubation with whole skin [4 ]. The mobility of 
Peaks I to V in system PG corresponded to that of 
the metabolites previously identified: 
Peak 1: 5a-pregnane-3,17-dione 
Peak II: progesterone and 3a-hydroxy-5a-
pregnan-20-one 
Peak III: 3~-hydroxy-5a-pregnan-20-one 
Peak IV: 20a-hydroxypregn-4-en-3-one (20a-
DHP) and 5a-pregnane-3a,20a-diol 
Peak V: 5a-pregnane-313,20a-diol 
The 6th area of radioactivity remained at the 
origin and was not previously identified. 
Incubation of progesterone with 2 ml of the 
microsomal fraction ( 100,000 x: g pellet) and 
co!actors resulted in a chromatogram lacking 
peaks IV and V, indicating the absence of metabo-
lites with side chains reduced at C-20. The forma-
tions of peaks I and III indicate the reduction of the 
A '-double bond of progesterone, resulting in the 
formation of products previously identified as 
5a- pregnane-3,20-dione and 3/3-hydroxy-5a-preg-
nan -20-one. 
In contrast, incubation with the soluble (100,000 
x g supernatant) fraction and the same cofactors 
produced a large peak IV, while radioactivity in 
peaks I and III was minimal. Since incubations 
with whole skin produce a peak IV consisting of 
two metabolites, 20a-hydroxypregn-4-en-3-one 
(20a-DHP) and 5a-pregnane-3a,20a-diol, the 
peak IV produced by the soluble fraction was 
eluted from the chromatogram, mixed with proges-
terone, 20a-DHP and 5a-pregnane-3a,20a-diol 
standards, and chromatographed in system 
TLC-CM-4. Virtually all of the radioactivity in 
this chromatogram had the mobility of 20a-DHP 
and no discernible peak corresponded to the posi-
tion of the 5a-pregnane-3a.20a-diol. 
These data indicate that the 5a-reductase for 
progesterone is predominantly particulate while 
the 20a-HSD is a soluble enzyme. The localization 
of the 3a or 3tl-hydroxysteroid dehydrogenases 
must await studies utilizing substrates without 
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the.i •-double bond, because the reduction of the 
ketone at position 3 is markedly retarded by a, 
,6-unsaturation at c •. Thus, the absence of reduc-
tion of the 3-ketone by the soluble fraction may 
indicate a lack of reduction of the .1. •-double bond 
rather than the absence of soluble 3a- or 3,6-hydroxy-
steroid dehydrogenases in this fraction. 
Cofactor specificity of 5a-reductase. An aliquot 
of the microsomal fraction was incubated with 
progesterone-4- 14C with and without the addition 
of TPNH or DPNH. In the absence of TPNH, no 
5a-metabolites were formed, while with TPNH 
present 551 pmoles were produced. These results 
indicate that the reduction of the double bond of 
progesterone, like that of testosterone [6 J, required 
TPNH and that DPNH does not function as a 
cofactor. 
Cofactor specificity of 20a-HSD. Incubation of 
progesterone-4-ac with the soluble fraction in the 
absence of added cofactors resulted in the forma-
tion of 160 pmoles of 20a-DHP. Addition of 
DPNH resulted in a slight stimulation, yielding 
360 pmoles, while the addition of TPNH markedly 
stimulated the reaction, yielding 2, 710 pmoles. 
These data indicate that cutaneous 20a-HSD uti-
lizes TPNH as the preferred cofactor. 
Stability of cutaneous 20a-HSD. To examine the 
stability of 20a-HSD prior to further characteriza-
tion, a single batch of the 105.000 x g supernatant 
was assayed immediately after preparation, after 
storage for 4 days at 4°C, and for 1 month at 
-60°C. The results indicated that the activity was 
stable on freezing and at refrigerator temperature 
for the periods tested. 
Time course of side chain reduction. The single 
extraction method was used to further study 20a-
HSD. Figure 1 shows the time course of the 
reduction of the 20-ketone of progesterone using 
this method. At 37°C the reaction was linear for at 
least 3 hr. For convenience, an incubation time of 1 
hr was subsequently used. 
pH Optimum of 20a-HSD. To determine the 
optimum pH for this reaction, supernatant (pH 
7.4) was dialyzed for 9 hr at 4 °C against 0.1 M 
phosphate buffer (pH 7 .0). Aliquots of the superna-
tant were then adjusted to various pH values by 
addition of small volumes of HCl or NaOH and the 
activity assayed. The maximum production of 
20a-DHP occurred at pH 6.0. Since phosphate is a 
poor buffer in this pH range. the dialysis was 
repeated using buffer containing 0.1 M phosphate 
and 0.05 M citrate and having a pH of 6.0. After 
dialyzing and adjusting to the desired pH value, 
the activity was assayed. The results are summa-
rized in Figure 2. Activity was greatest at pH 6.2 
and declined rapidly at more acidic or basic pH's. 
Between pH 7.5 and 8.5 the activity remained 
constant. 
Km of 20a-HSD for progesterone. The effect of 
varying substrate concentration in the reaction 
mixture was examined. The results (Fig. 3a) indi-
cated a Km of approximately 7 p. M. 
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Linearity of assay for 20a-HSD. The variation of 
activity with different volumes of supernatant 
(varying amounts of enzyme) was examined (Fig. 
3b). The reaction rates were found to be linear with 
a protein concentration up to 3.5 mg per incuba-
tion mixture (equivalent to 1 ml of undiluted 
supernatant per incubation mixture). 
Assay of 20a-HSD and 17(3-HSD in 105,000 x g 
supernatant. Davis [8) found that a minor portion 
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FIG. 1. Time course of the 20a-hydrosteroid dehydro-
genase reaction using the single extraction method. 
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FIG. 2. The pH dependence of the 20a-hydrosteroid 
dehydrogenase reaction. Abscissa, pH; ordinate, pmoles 
of 20a-hydroxypregn-4-en-3-one (20a-DHP) formed per 
mg protein in 1 hr. Buffers: 0.1 M phosphate buffer 
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FIG. 3. a: Kinetic plot of the 20a-hydrosteroid dehydro-
genase reaction by the method of Eadie. b: Dependence 
of product (20a-DHPl formation on amount of enzyme 
preparation. In both experiments the 105,000 x g super-
natant was adjusted to pH 6.2 by dialysis against 
PO,-citrate buffer of the same pH and the single extrac. 
tion method used to measure enzyme activity 
TABLE. 17 {J-HSD and 20a-HSD activity in skin 
supematanta 
Product (pmoles) 
Substrate- Enzyme Cofactor Me as- Corrected~ 
ured 
Estrone 1 ml TPNH 116 85 
Estrone 1 ml DPNH 154 123 
Estrone 1 ml - 93 62 
Estrone - - 31 -
Progesterone 1 ml TPNH 379 379 
Progesterone 1 ml DPNH 48 48 
Progesterone 1 ml - 6 6 
Progesterone - - 0 -
"Assay system was the single extraction method as 
described in Materials and Methods. 
'Corrected for spontaneous decomposition of sub-
strate. 
of human cutaneous 17!'1-HSD remained in the 
105,000 x g supernatant. In view of the report by 
Purdy et al 113] that 20a-HSD activity of human 
placenta is a minor activity of a soluble 17!'1-HSD 
catalyzing the reduction of estrone to form estradi-
ol-17!'1, the 105,000 x g supernatant was simultane-
ously assayed for 20a-HSD and 17!'1-HSD activi-
ties. The results are shown in the Table. With 
estrone as substrate, a net production of 62 pmoles 
of estradiol-171'1 was found in the absence of cofac-
tors, 85 pmoles with TPNH added, and 123 with 
DPNH added. The level of estrone decomposition 
found is similar to that found in Davis [8 ]. With 
progesterone as substrate only 6 pmoles of 20a-
DHP were produced in the absence of cofactor, 48 
pmoles with DPNH added, and 379 pmoles with 
TPNH added. 
DISCUSSION 
The Sa-reductase from human skin which con-
verts testosterone to dihydrotestosterone is a mem-
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brane-bound, TPNH-lined enzyme. Cross-inhibi-
tion studies suggest that the same enzyme may 
also reduce the ~'-double bond of progesterone 16 ). 
The present data confirm that the progesterone 
reductase activity is predominantly membrane 
bound and, as with testosterone as substrate, is 
TPNH dependent. Little is known of the 3a-HSD 
and 3!'1-HSD of human skin, but Davis [8] has 
shown that the cutaneous 17!'1-HSD is also predom-
inantly membrane bound and utilizes DPNH in 
preference to TPNH. Since virtually all the 20a-
HSD activity in skin is in the soluble fraction, it 
appears that this activity is catalyzed by a differ-
ent enzyme from that responsible for cutaneous 
171'1-HSD activity. An additional difference is co-
factory specificity: the 20a-HSD utilizes TPNH in 
preference to DPNH. These data indicate that 
cutaneous 20a-HSD is distinct from the micro-
somal enzymes of broad specificity described by 
Voigt et al 16) and Davis [8]. 
Purdy et al [13] have investigated the 20a-HSD 
activity of human placenta and reported this 
activity to be a minor activity of the placental 
17!'1-HSD which utilizes estradiol-171'1 or estrone as 
substrates. Estrogens appear to be the preferred 
substrates of the placental preparations, since the 
Km for estrone was .~.6 I'M while that for progester-
one was 180 !LM. The apparent Km for progester-
one of the cutaneous 20a-HSD described in the 
present study is about 1/25 that reported by 
Purdy et al [13 J for the placental enzyme. Like-
wise, in placental preparations. the maximum 
reaction velocity with estrone as substrate is ap-
proximately 46 times greater than with progester-
one [13]. The low 171'1-HSD activity in skin super-
natants appears to be less than that of 20a-HSD, 
indicating that in skin the reduction of the proges-
terone side chain is unlikely to be due to the 
placental enzymes. 
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